Antibody–drug conjugates for the treatment of urothelial carcinoma
Author:
Affiliation:
1. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Funder
funded
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1789096
Reference53 articles.
1. Cancer statistics, 2020
2. Cancer Stat Facts - Bladder Cancer. SEER Program. cited 2020 Apr 15. Available from: https://seer.cancer.gov/statfacts/html/urinb.html
3. Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG).
4. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
5. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy;Biomedicine & Pharmacotherapy;2024-02
2. Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma;Frontiers in Oncology;2023-01-04
3. An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next;Cancer Chemotherapy and Pharmacology;2022-08-11
4. Combination of T-DM1 and platinum-based chemotherapy in patient-derived xenograft models of muscle-invasive bladder cancer;IRAN J BASIC MED SCI;2022
5. Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma;Expert Opinion on Biological Therapy;2021-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3